Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated:  12/31/1969
Banner University Medical Center
mi
from
Phoenix, AZ
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated: 12/31/1969
Banner University Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated:  12/31/1969
Baptist Hospital of Miami
mi
from
Miami, FL
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated: 12/31/1969
Baptist Hospital of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated:  12/31/1969
Mayo Foundation for Medical Education and Research
mi
from
Rochester, MN
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated: 12/31/1969
Mayo Foundation for Medical Education and Research
mi
from
Rochester, MN
Click here to add this to my saved trials
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated:  12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated:  12/31/1969
Bon Secours St. Mary's Hospital
mi
from
Richmond, VA
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Enrolling
Updated: 12/31/1969
Bon Secours St. Mary's Hospital
mi
from
Richmond, VA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Heart Center Research, Llc
mi
from
Huntsville, AL
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Heart Center Research, Llc
mi
from
Huntsville, AL
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Tri-Lakes Research
mi
from
Hot Springs, AR
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Tri-Lakes Research
mi
from
Hot Springs, AR
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
University of Florida - Jacksonville
mi
from
Jacksonville, FL
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Tallahassee Research Institute
mi
from
Tallahassee, FL
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Tallahassee Research Institute
mi
from
Tallahassee, FL
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
North Georgia Heart Foundation
mi
from
Gainesville, GA
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
North Georgia Heart Foundation
mi
from
Gainesville, GA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Jesse Brown VA Medical Center
mi
from
Chicago, IL
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Jesse Brown VA Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Jewish and St. Mary's Hospital
mi
from
Louisville, KY
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Jewish and St. Mary's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
McLaren Bay Region
mi
from
Bay City, MI
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
McLaren Bay Region
mi
from
Bay City, MI
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
MidMichigan Medical Center - Midland
mi
from
Midland, MI
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
MidMichigan Medical Center - Midland
mi
from
Midland, MI
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
William Beaumont Hospital
mi
from
Royal Oak, MI
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Missouri Cardiovascular Specialists, LLP
mi
from
Columbia, MO
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Missouri Cardiovascular Specialists, LLP
mi
from
Columbia, MO
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
University at Buffalo
mi
from
Buffalo, NY
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
University at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center and the New York Presbyterian Hospital
mi
from
New York, NY
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center and the New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Novant Health Heart and Vascular Institute
mi
from
Charlotte, NC
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Novant Health Heart and Vascular Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
LeBauer Cardiovascular Research Foundation
mi
from
Greensboro, NC
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
LeBauer Cardiovascular Research Foundation
mi
from
Greensboro, NC
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
NC Heart and Vascular Research
mi
from
Raleigh, NC
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
NC Heart and Vascular Research
mi
from
Raleigh, NC
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Genesis Healthcare System
mi
from
Zanesville, OH
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Genesis Healthcare System
mi
from
Zanesville, OH
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Berks Cardiologists, Ltd.
mi
from
Reading, PA
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Berks Cardiologists, Ltd.
mi
from
Reading, PA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Pinnacle Health Cardiovascular Institute
mi
from
Wormleysburg, PA
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Pinnacle Health Cardiovascular Institute
mi
from
Wormleysburg, PA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
AnMed Health
mi
from
Anderson, SC
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
AnMed Health
mi
from
Anderson, SC
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Black Hills Cardiovascular Research
mi
from
Rapid City, SD
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Black Hills Cardiovascular Research
mi
from
Rapid City, SD
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Chattanooga Heart Institute
mi
from
Chattanooga, TN
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Chattanooga Heart Institute
mi
from
Chattanooga, TN
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Tennova Healthcare - Turkey Creek Medical Center
mi
from
Knoxville, TN
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Tennova Healthcare - Turkey Creek Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Providence Health Center
mi
from
Waco, TX
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Providence Health Center
mi
from
Waco, TX
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Carilion Clinic
mi
from
Roanoke, VA
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Carilion Clinic
mi
from
Roanoke, VA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Scripps Health
mi
from
La Jolla, CA
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Scripps Health
mi
from
La Jolla, CA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Velella Research
mi
from
Sarasota, FL
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Velella Research
mi
from
Sarasota, FL
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
St. Luke's Idaho Cardiology Associates
mi
from
Boise, ID
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
St. Luke's Idaho Cardiology Associates
mi
from
Boise, ID
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
St. Vincent Heart Center
mi
from
Indianapolis, IN
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
St. Vincent Heart Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Lahey Clinic
mi
from
Burlington, MA
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical College-New York Presbyterian
mi
from
New York, NY
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical College-New York Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated:  12/31/1969
Mazankowski Alberta Heart Institute
mi
from
Edmonton,
LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Status: Enrolling
Updated: 12/31/1969
Mazankowski Alberta Heart Institute
mi
from
Edmonton,
Click here to add this to my saved trials
Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.
Observational Investigation to Determine Clinical Impact of Continuous Surveillance Monitoring (SM) on General Care Floors With a Nested Study to Determine the Clinical Utility of IPI (Integrated Pulmonary Index).
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.
Observational Investigation to Determine Clinical Impact of Continuous Surveillance Monitoring (SM) on General Care Floors With a Nested Study to Determine the Clinical Utility of IPI (Integrated Pulmonary Index).
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fairhope, AL
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fairhope, AL
Click here to add this to my saved trials